查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590818

基因組編輯市場：按技術、應用和最終用戶分類 - 2025-2030 年全球預測

Genome Editing Market by Technology (Antisense, CRISPR, Talen), Application (Cell Line Engineering, Genetic Engineering), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因組編輯市場價值為108億美元，預計到2024年將達到165.4億美元，複合年成長率為53.22%，到2030年將達到2142.2億美元。

基因組編輯是一種修改生物體 DNA 的科學方法，在從農業到醫療保健的廣泛應用中獲得了大力支持。這項技術對於創造具有特定所需性狀的基因改造生物、解決農作物抗病性和醫療保健治療方法開發進展等問題至關重要。對基因組編輯的需求源於其透過實現精確且具有成本效益的基因改造來解決糧食安全和遺傳疾病等緊迫世界問題的潛力。其主要用途是在農業領域開發抗害蟲產量的作物，以及在醫療保健領域以基因療法為中心治療遺傳性疾病。此外，用於生質燃料生產的工業生物技術和環境技術正在取得突破。

主要市場統計
基準年[2023] 108億美元
預測年份 [2024] 165.4億美元
預測年份 [2030] 2142.2億美元
複合年成長率（%） 53.22%

基因組編輯市場的成長主要是由對先進治療解決方案的需求不斷成長、生物技術的持續進步以及對遺傳疾病的日益了解所推動的。最新的機會包括擴大 CRISPR 在治療和作物改良計劃中的應用，以支持永續和有彈性的糧食系統。投資研究機構或與研究機構合作的公司可以利用基因組編輯的專利新技術，獲得監管部門的核准，並儘早進入新興市場。對公司的主要建議是專注於開發更高精度和更少脫靶效應的基因編輯工具，並擴大夥伴關係以增強研發能力。

然而，市場面臨重大挑戰，包括對基因改造的倫理擔憂、嚴格的法規環境以及可能影響市場採用的潛在社會經濟差異。公眾意識和道德辯論可能會限制某些地區對該技術的接受，需要透明的溝通和社區參與努力。創新應著重於開發下一代編輯工具，例如鹼基編輯器，改善治療應用的交付機制，並透過與政策制定者的積極對話解決監管瓶頸。基因組編輯市場的特點是技術快速發展，如果能夠熟練地應對倫理和監管環境，就可以為公司的創新提供肥沃的土壤。

市場動態：揭示快速發展的基因組編輯市場的關鍵市場洞察

供需的動態交互作用正在改變基因組編輯市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 政府資助和基因組學計劃數量的增加
    • 拓展基因體學的應用領域
    • 感染疾病和癌症發生率高
    • 基因改造作物產量增加
  • 市場限制因素
    • 缺乏訓練有素的專業人員
    • 基因研究的社會評估下降
  • 市場機會
    • 基因組編輯在專業醫學的應用
    • 使用 CRISPR-Cas9 系統進行基因組編輯的進展
  • 市場挑戰
    • 基因組分析設備高成本
    • 大量序列資料的安全存儲

波特的五力：駕馭基因組編輯市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因組編輯市場的外部影響

外部宏觀環境因素在塑造基因組編輯市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因組編輯市場的競爭狀況

對基因組編輯市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因組編輯市場供應商績效評估

FPNV定位矩陣是評估基因組編輯市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因組編輯市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對基因組編輯市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加政府資助和增加基因組學計劃數量
      • 拓展基因體學的應用領域
      • 感染疾病和癌症發生率高
      • 基因改造作物產量增加
    • 抑制因素
      • 受過訓練的專業人員數量有限
      • 公眾對基因研究的負面看法
    • 機會
      • 基因組編輯在專業醫學的應用
      • 使用 CRISPR-Cas9 系統進行基因組編輯的進展
    • 任務
      • 與基因組設備相關的高成本
      • 大量序列資料的安全存儲
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因組編輯市場：依技術分類

  • 反義
  • 更脆的
  • 塔倫
  • 鋅指核酸酶

第7章 基因組編輯市場：依應用分類

  • 細胞株工程
  • 基因工程
    • 動物基因工程
    • 植物性因工程

第 8 章 基因組編輯市場：依最終使用者分類

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約調查機構

第9章 北美和南美基因組編輯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區基因組編輯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的基因組編輯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • AgriGenome Labs Pvt. Ltd.
  • Beam Therapeutics Inc.
  • Biocompare, Inc.
  • Danaher Corporation
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Lonza Group AG
  • Merck KGaA
  • OriGene Technologies, Inc.
  • PerkinElmer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sangamo Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • Verve Therapeutics, Inc.
Product Code: MRR-431C35F6C15D

The Genome Editing Market was valued at USD 10.80 billion in 2023, expected to reach USD 16.54 billion in 2024, and is projected to grow at a CAGR of 53.22%, to USD 214.22 billion by 2030.

Genome editing, the scientific approach to modifying an organism's DNA, has gained significant traction in applications ranging from agriculture to health care. This technology is pivotal for its ability to create genetically modified organisms with specific desired traits, addressing issues such as disease resistance in crops and advancing therapeutic development in healthcare. The necessity of genome editing stems from its potential to solve pressing global issues, including food security and genetic disorders, by enabling precise and cost-effective genetic modifications. Its primary applications are in agriculture, for developing pest-resistant and higher-yield crops, and in healthcare, particularly in gene therapy to treat genetic conditions. Additionally, it's making strides in industrial biotechnology for biofuel production and environmental technology.

KEY MARKET STATISTICS
Base Year [2023] USD 10.80 billion
Estimated Year [2024] USD 16.54 billion
Forecast Year [2030] USD 214.22 billion
CAGR (%) 53.22%

Market growth in genome editing is primarily driven by increasing demand for advanced therapeutic solutions, continuous advancements in biotechnology, and a growing understanding of genetic diseases. The latest opportunities include expanding CRISPR applications in therapeutics and crop improvement programs to support sustainable and resilient food systems. Companies that invest in and partner with research institutions can leverage new patentable techniques in genome editing, gain regulatory approvals, and achieve early entry into emerging markets. Key recommendations for businesses would be to focus on developing gene editing tools with higher accuracy and fewer off-target effects, and the expansion of partnerships to enhance R&D capabilities.

However, the market faces significant challenges such as ethical concerns over genetic modifications, stringent regulatory environments, and potential socio-economic disparities impacting market adoption. Public perception and ethical debates could limit technology acceptance in some regions, necessitating transparent communication and community engagement initiatives. Innovation should focus on creating next-gen editing tools like base editors, improving delivery mechanisms for therapeutic applications, and addressing regulatory bottlenecks through proactive dialogue with policymakers. The genome editing market is characterized by rapid technological evolution, offering a fertile ground for businesses to innovate, provided they navigate ethical and regulatory landscapes adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Editing Market

The Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government funding and growth in the number of genomics Projects
    • Growing application areas of genomics
    • High prevalence of infectious diseases and cancer
    • Increasing production of genetically modified crops
  • Market Restraints
    • Limited availability of trained professionals
    • Adverse public perception of genetic research
  • Market Opportunities
    • Use of genome editing in specialized medicine
    • Advancements in genome editing with CRISPR-Cas9 system
  • Market Challenges
    • High cost associated with genomics equipment
    • Secure storage of large volumes of sequenced data

Porter's Five Forces: A Strategic Tool for Navigating the Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Editing Market

A detailed market share analysis in the Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Editing Market

A strategic analysis of the Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, AgriGenome Labs Pvt. Ltd., Beam Therapeutics Inc., Biocompare, Inc., Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Lonza Group AG, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases.
  • Based on Application, market is studied across Cell Line Engineering and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering and Plant Genetic Engineering.
  • Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government funding and growth in the number of genomics Projects
      • 5.1.1.2. Growing application areas of genomics
      • 5.1.1.3. High prevalence of infectious diseases and cancer
      • 5.1.1.4. Increasing production of genetically modified crops
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of trained professionals
      • 5.1.2.2. Adverse public perception of genetic research
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of genome editing in specialized medicine
      • 5.1.3.2. Advancements in genome editing with CRISPR-Cas9 system
    • 5.1.4. Challenges
      • 5.1.4.1. High cost associated with genomics equipment
      • 5.1.4.2. Secure storage of large volumes of sequenced data
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genome Editing Market, by Technology

  • 6.1. Introduction
  • 6.2. Antisense
  • 6.3. CRISPR
  • 6.4. Talen
  • 6.5. Zinc Finger Nucleases

7. Genome Editing Market, by Application

  • 7.1. Introduction
  • 7.2. Cell Line Engineering
  • 7.3. Genetic Engineering
    • 7.3.1. Animal Genetic Engineering
    • 7.3.2. Plant Genetic Engineering

8. Genome Editing Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Genome Editing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Genome Editing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Genome Editing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. AgriGenome Labs Pvt. Ltd.
  • 3. Beam Therapeutics Inc.
  • 4. Biocompare, Inc.
  • 5. Danaher Corporation
  • 6. Editas Medicine, Inc.
  • 7. GenScript Biotech Corporation
  • 8. Lonza Group AG
  • 9. Merck KGaA
  • 10. OriGene Technologies, Inc.
  • 11. PerkinElmer Inc.
  • 12. Regeneron Pharmaceuticals, Inc.
  • 13. Sangamo Therapeutics, Inc.
  • 14. Thermo Fisher Scientific Inc.
  • 15. Verve Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. GENOME EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOME EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOME EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOME EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOME EDITING MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOME EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOME EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOME EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOME EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023